American Brain Tumor Association Awards 20 Research Grants to Advance Brain Tumor Science and Discoveries
09 Nov 2022
Immunotherapy
CHICAGO, Nov. 9, 2022 /PRNewswire/ -- The American Brain Tumor Association (ABTA) today announced the funding of $821,000 towards 20 new research grants to advance brain tumor science and treatments. With more than $34 million invested in research to date, across all brain tumor types and ages, the ABTA research program plays a critical role in advancing the understanding of brain tumors and building the next generation of brain tumor researchers.
"With more than $34 million invested to support 780 research projects, the ABTA continues to drive brain tumor research forward to discover new treatments for a ruthless and often deadly disease," said Nicole Willmarth, Ph.D., ABTA's chief mission officer. "Thanks to the generous support from donors and partners, including our newest partners StacheStrong and Brain Tumour Foundation of Canada, the ABTA is able to expand its research investment."
This year's slate of research projects investigates the use of biomarkers, genetics, epigenetics, imaging, and immunotherapy for adult and pediatric brain tumors.
The ABTA congratulates the 2022 grant recipients listed below. To learn more about the grant recipients and their research projects, visit www.abta.org/research/research-funding-impact/.
Basic Research Fellowships are two-year, $100,000 grants awarded to post-doctoral fellows who are mentored by established and nationally recognized experts in the neuro-oncology field.
Kristen Huntoon, DO, PhD, University of Texas M.D. Anderson Cancer Center
Aram Modrek, MD, PhD, New York University School of Medicine
Discovery Grants are one-year, $50,000 grants supporting high risk, innovative approaches that hold potential to change current diagnostic or treatment standards of care.
Floris Barthel, MD, The Translational Genomics Research Institute, Arizona
Andrew Beharry, PhD, University of Toronto, Canada
Aashim Bhatia, MD, The Children's Hospital of Philadelphia
Henk De Feyter, PhD, Yale University, Connecticut
Edjah Nduom, MD, Emory University, Georgia
An-Chi Tien, PhD, Barrow Neurological Institute–St. Joseph Medical Center, Arizona
Pavithra Viswanath, PhD, University of California, San Francisco
Jacky Yeung, MD, Yale University, Connecticut
Fan Zhang, PhD, University of Florida
Medical Student Summer Fellowships are three-month, $3,000 grants awarded to medical students to conduct brain tumor research projects under the guidance of neuro-oncology experts. Through these grants, the ABTA seeks to encourage physician-scientists to enter and remain in the brain tumor field.
Shreya Budhiraja, BA, Northwestern University, Illinois
Eric Chalif, BA, University of California, San Francisco
Stephen Frederico, MS, Children's Hospital of Pittsburgh
David Hou, BA, Northwestern University, Illinois
Kyle McGrath, BS, University of Florida
Kashayar Mozaffari, BS, University of California, Los Angeles
Janet Wu, BA, BM, Stanford University, California
The ABTA is now accepting applications for its 2023 Research Collaboration Grants, Discovery Grants, Basic Research Fellowships, and Jack and Fay Netchin Medical Student Summer Fellowships. For more information on grant opportunities and deadlines, visit https://www.abta.org/grants/.
About American Brain Tumor Association
Founded in 1973, the American Brain Tumor Association provides comprehensive resources to support the complex needs of brain tumor patients and caregivers, across all ages and tumor types, as well as the critical funding of research in pursuit of breakthroughs in brain tumor diagnoses, treatments, and care. To learn more, visit ABTA.org or call 1-800-886-ABTA (2282).
SOURCE American Brain Tumor Association
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.